Chembio Diagnostics, Inc. financial data

Industry
Pharmaceutical Preparations
Location
555 Wireless Blvd., Hauppauge, NY
State of incorporation
NV
Fiscal year end
December 31
Former names
TRADING SOLUTIONS COM INC (to 6/7/2004)
Latest financial report
10-K - Q4 2022 - Mar 29, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 175 % -53.9%
Quick Ratio 37.3 % -71.8%
Debt-to-equity 197 % +65.4%
Return On Equity -114 % -0.97%
Return On Assets -38.2 % +25.5%
Operating Margin -47.7 % +26.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.7M shares +22.2%
Common Stock, Shares, Outstanding 36.8M shares +22.1%
Entity Public Float 18.7M USD
Common Stock, Value, Issued 368K USD +22.1%
Weighted Average Number of Shares Outstanding, Basic 32.3M shares +32.8%
Weighted Average Number of Shares Outstanding, Diluted 32.3M shares +32.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 49.5M USD +3.56%
Cost of Revenue 38.6M USD +11.8%
Research and Development Expense 7.07M USD -43.4%
Costs and Expenses 73.2M USD -7.24%
Operating Income (Loss) -23.6M USD +23.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.3M USD +31.5%
Income Tax Expense (Benefit) 34.4K USD +373%
Net Income (Loss) Attributable to Parent -23.3M USD +31.3%
Earnings Per Share, Basic -0.72 USD/shares +48.6%
Earnings Per Share, Diluted -0.72 USD/shares +48.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.2M USD -36.8%
Accounts Receivable, after Allowance for Credit Loss, Current 6.54M USD -42.9%
Inventory, Net 7.72M USD -40.3%
Assets, Current 48.5M USD -11.7%
Property, Plant and Equipment, Net 8.15M USD -4.7%
Operating Lease, Right-of-Use Asset 5.43M USD -7.79%
Goodwill 0 USD -100%
Assets 62.6M USD -14.5%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 39.3M USD +157%
Operating Lease, Liability, Noncurrent 5.43M USD -9.21%
Other Liabilities, Noncurrent 10.7K USD
Liabilities 44.8M USD +14.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -337K USD +43.1%
Retained Earnings (Accumulated Deficit) -154M USD -17.8%
Stockholders' Equity Attributable to Parent 17.8M USD -48.1%
Liabilities and Equity 62.6M USD -14.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.37M USD +39.8%
Net Cash Provided by (Used in) Financing Activities -55.4K USD +57.1%
Net Cash Provided by (Used in) Investing Activities -287K USD +76.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 36.8M shares +22.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.37M USD +49.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.2M USD -36.8%
Deferred Tax Assets, Valuation Allowance 27.9M USD +16.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure -125%
Deferred Tax Assets, Gross 29.3M USD +13.3%
Operating Lease, Liability 6.34M USD -7.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23M USD +33%
Lessee, Operating Lease, Liability, to be Paid 8.42M USD -11%
Property, Plant and Equipment, Gross 20.3M USD +7.7%
Operating Lease, Liability, Current 915K USD +3.22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD -0.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.43M USD -1.27%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +12.4%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.08M USD -19.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.05M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 22.1M USD +8.44%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.08M USD +3%
Operating Lease, Payments 1.45M USD +3.51%
Additional Paid in Capital 172M USD +3.92%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 599K USD -12.9%
Share-based Payment Arrangement, Expense 2.3M USD +13%